OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review
Yingda Lin, Fuming He, Ling Wu, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 533-569
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Unlocking the Potential of Oxymatrine: A Comprehensive Review of Its Neuroprotective Mechanisms and Therapeutic Prospects in Neurological Disorders
Yogita Dhurandhar, Shubham Tomar, Ashmita Das, et al.
ACS Chemical Neuroscience (2024)
Closed Access | Times Cited: 2

Antifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
Hua Zhong, Lei Han, Ren-Yi Lu, et al.
Antibiotics (2022) Vol. 12, Iss. 1, pp. 48-48
Open Access | Times Cited: 10

Matrine family derivatives: Synthesis, reactions procedures, mechanism, and application in medicinal, agricultural, and materials chemistry
Jamal A.H. Kowah, Ruobing Gao, Fu Li, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 7, pp. 100098-100098
Open Access | Times Cited: 8

Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity
Mariana Medeiros, Sophia Guenka, David Bastos, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 734-734
Open Access | Times Cited: 1

The Search for Drugs Derived from Natural Products for Toxoplasma gondii Infection Treatment in the Last 20 Years - A Systematic Review
Fabielle Marques-Santos, Robson Xavier Faria, Maria Regina Reis Amendoeira
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 22, pp. 1960-1999
Closed Access | Times Cited: 1

MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway
Shijie Wei, Yubao Zhang, Xiaoran Ma, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3

Synthesis and Evaluation of 11-Butyl Matrine Derivatives as Potential Anti-Virus Agents
Wanjun Ni, Lizhong Wang, Hongjian Song, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7563-7563
Open Access | Times Cited: 3

Matrine inhibits cell proliferation, invasion, and stem cell formation in hepatocellular carcinoma by regulating the ELAVL1/RBM3‐mediated Wnt/β‐catenin signaling pathway
Chunhua Song, Hongwei Li, Zhengchun Huang, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access

Past, Present, and Future of Alkaloid-Based Anticancer Agents
W. H. P. A. D. Perera, Mithuni N. Senadeera, Dinusha N. Udukala
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 22-47
Closed Access

Deciphering Matrine's Therapeutic Mechanism in Osteosarcoma: Insights from Network Pharmacology and Single-Cell RNA Sequencing
Wenkai Xie, Tianjun Ma, Hong Wu, et al.
Indian Journal of Pharmaceutical Sciences (2024) Vol. 86, Iss. S2
Open Access

The mechanism of Traditional Mongolian medicine Daruqi particles on inflammation
Zhi Liu, Zhiqiang Han, L. K. Xue, et al.
Gene (2024) Vol. 920, pp. 148530-148530
Closed Access

MASM inhibits cancer stem cell-like characteristics of EpCAM+ cells via AKT/GSK3β/β-catenin signaling.
Keyan Sun, Huaxing Shen, Shipeng He, et al.
PubMed (2022) Vol. 14, Iss. 11, pp. 8380-8389
Closed Access | Times Cited: 1

[Effects of matrine combined with LY294002 on proliferation, apoptosis and cell cycle of human myeloid leukemia K562 cells].
Hao Yan-mei, J Ji, C Liu, et al.
PubMed (2022) Vol. 42, Iss. 11, pp. 1739-1746
Closed Access

Previous Page - Page 2

Scroll to top